Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
11
2019
USPTO Issues Examination Guide on Trademark Applications for Cannabis and Cannabis-Related Goods and Services Brinks Gilson & Lione
Jun
11
2019
Navigating the Legalization of Hemp under the 2018 Farm Bill Involves Changes to the Issuance of Federal Trademarks in the Cannabis Industry Mintz
Jun
11
2019
Occupations Governed by Federal Regulation Remain Guarded Against State Medical Marijuana Non-Discrimination Laws Jackson Lewis P.C.
Jun
11
2019
Deadlines Set for FDA to Establish Reporting Requirements for “High-Risk” Foods Keller and Heckman LLP
Jun
11
2019
Nevada Will Ban Pre-Employment Marijuana Testing On January 1, 2020 Jackson Lewis P.C.
Jun
10
2019
New Jersey’s Department of Health Announces Plan to Expand Its Medicinal Marijuana Program Wilson Elser Moskowitz Edelman & Dicker LLP
Jun
10
2019
Weeding Out the Issues of Legalizing Recreational Marijuana in Illinois ArentFox Schiff LLP
Jun
10
2019
FDA Forms PFAS Working Group Keller and Heckman LLP
Jun
10
2019
FDA Deputy Commissioner Yiannis’ Remarks on World Food Safety Day Keller and Heckman LLP
Jun
10
2019
If the DEA Does Not Quickly Reexamine Marijuana’s Classification Under the Controlled Substance Act, the Second Circuit Might McDermott Will & Emery
Jun
10
2019
Asbestos Receiving Renewed Attention in Light of Additional US EPA Assessments under TSCA and Potential Ban by Congress Squire Patton Boggs (US) LLP
Jun
8
2019
APHIS Proposes Revised Regulatory Framework Regarding the Movement of Certain Genetically Engineered Organisms Bergeson & Campbell, P.C.
Jun
7
2019
Companies Collaborate To Launch Sustainability Funding Opportunity Bergeson & Campbell, P.C.
Jun
7
2019
EPA Issues In Final Regulatory Changes Allowing E15 Sale Year-Round Bergeson & Campbell, P.C.
Jun
7
2019
USDA Removes Standard for “Jambalaya” Keller and Heckman LLP
Jun
7
2019
AATF Initiative Makes GM Seeds Available For Seed Companies In Africa Bergeson & Campbell, P.C.
Jun
7
2019
Learnings from the FDA Hearing on Cannabis and Cannabis-Derived Compounds McDermott Will & Emery
Jun
7
2019
ISO Guidance Specifies Characteristics and Measurement Methods for Antibacterial Silver Nanoparticles Bergeson & Campbell, P.C.
Jun
6
2019
Hemp News: Updates on Interstate Travel, Interstate Commerce, and Crop Insurance Ward and Smith, P.A.
Jun
6
2019
OEHHA Confirms Final Carcinogen/Coffee Rule on Twitter Keller and Heckman LLP
Jun
6
2019
USDA Issues Legal Opinion on Hemp Beveridge & Diamond PC
Jun
6
2019
FDA Findings on PFAS Chemicals in U.S. Food and Drinking Water Supply Greenberg Traurig, LLP
Jun
5
2019
Update on Cannabis (Marijuana) Regulations in Mexico Greenberg Traurig, LLP
Jun
5
2019
CBD Industry Must Prepare For FDA Regulation Steptoe & Johnson PLLC
Jun
5
2019
FDA Publishes Draft Guidance to Assist in Developing Alternate Curricula to Satisfy Produce Safety Rule Requirements Keller and Heckman LLP
Jun
5
2019
Congressional Funding Bill Pursues Approval of Financial Services for Marijuana Industry Through the (Temporary) Backdoor Ballard Spahr LLP
Jun
5
2019
EPA Hazardous Waste Pharmaceuticals Rule Mandates Changes for Health Care Facilities Dinsmore & Shohl LLP
Jun
4
2019
CMS Publishes Long-Awaited Final Rule Requiring Drug Pricing Transparency Dinsmore & Shohl LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins